Human ERBB2 Stable Cell Line-T47D

The ERBB2 gene, also known as HER2, encodes a protein called human epidermal growth factor receptor 2, a receptor tyrosine kinase. This protein is involved in cell growth, proliferation, and differentiation. abnormalities in the ERBB2 gene lead to overexpression of the HER2 protein, which is commonly associated with the development of various cancers such as breast, gastric, and ovarian cancers.

Targeting the ERBB2 gene and its protein products has become a key strategy for the treatment of HER2-positive cancers. The development of targeted therapies such as monoclonal antibodies that specifically bind to the HER2 protein (e.g., trastuzumab) and small molecule inhibitors that block the activity of the HER2 protein has greatly improved the prognosis of patients with HER2-positive cancers.

In addition to its role in cancer therapy, the ERBB2 gene is an important biomarker for predicting prognosis and guiding the treatment of patients with various types of cancer. For example, overexpression or amplification of the HER2 gene can be used to identify patients who are more likely to benefit from targeted therapies.

In summary, the ERBB2 gene and its protein products play a critical role in cell growth and proliferation, and their aberrations have been linked to the development of various types of cancer. Targeting the ERBB2 gene and its protein products has emerged as an important strategy for the treatment and management of HER2-positive cancers, improving patient prognosis and providing valuable biomarkers for prognostic and therapeutic guidance.